{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/contraception-assessment/","result":{"data":{"firstChapter":{"id":"8d7c8a25-4e93-5a42-928f-f6611bb74f8b","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 07e6a8d2-fae4-496f-bc1a-06207dffe836 --><h1>Contraception - assessment: Summary</h1><!-- end field 07e6a8d2-fae4-496f-bc1a-06207dffe836 -->","htmlStringContent":"<!-- begin item 1c61fd36-ff66-4f8c-a7db-7f8b57504d39 --><!-- begin field df77852f-535d-4b1f-84dd-32803bfb49bb --><ul><li><div>An assessment should be carried out on all women requesting contraception to identify any relevant medical conditions or medication that could affect her choice of contraceptive method.</div></li><li>The UK Medical Eligibility Criteria (UKMEC) should be checked to ensure that the preferred method is not contraindicated.<ul><li>If the woman is considering sterilization, or natural family planning, the World Health Organization Medical Eligibility Criteria should be checked, as these methods are not covered by the UKMEC.</li></ul></li><li>Factors which should be considered when deciding upon a method of contraception include:<ul><li><div>Comorbidities and other conditions — cardiovascular disease (CVD) risk factors; diabetes mellitus; epilepsy; headache or migraine; hypertension; menorrhagia; fibroids; previous ectopic pregnancy; obesity; sexually transmitted infections (STIs) or pelvic inflammatory disease (PID); smoking; and venous thromboembolism (VTE).</div></li><li>Concurrent medication — liver enzyme-inducing drugs (such as medicines for epilepsy, anti-retrovirals and St John’s Wort) can affect some forms of contraception.<ul><li>If the woman is taking teratogenic drugs (for example lithium or warfarin), more effective methods of contraception should be used (such as a progestogen-only implant, or intrauterine contraception). </li></ul></li><li>Age of the woman — if approaching the menopause or under 18 years.</li></ul></li><li>Pregnancy should be excluded — any suitable method of contraception can then be considered.</li><li>If pregnancy cannot be excluded (for example, following emergency contraception) but the woman wishes to start contraception without delay, one of the following options can be considered:<ul><li>Combined oral contraceptives (COCs), combined transdermal patch (CTP) or combined vaginal ring (CVR).</li><li>Progestogen-only pill (POP).</li><li>Progestogen-only implant.</li><li>Progestogen-only injectables — if other methods are not appropriate or acceptable.</li><li>A pregnancy test should be performed no sooner than 3 weeks after the last episode of unprotected sex.</li></ul></li><li>The woman's risk of sexually transmitted infections (STIs) should be assessed and advice about safe sex should be given when appropriate. </li><li>Choice of contraception should take into account the woman's preferences and her:<ul><li>Requirements for contraception, including future plans for having children, and the attitudes of her partner and her family towards contraception.</li><li>Personal beliefs and views about contraception.</li><li>Understanding of her preferred method, its efficacy, risks and adverse effects, advantages and disadvantages, and how to use it.</li></ul></li><li>Advice should be offered on long-acting reversible contraception (copper intrauterine device, levonorgestrel intrauterine system, progestogen-only injectables, progestogen-only implant, and the combined vaginal ring).</li><li>Girls younger than 16 years of age should be assessed for their competency to independently consent to treatment, and it should be documented in the case notes whether or not she meets the Fraser Criteria.</li><li>A young person's competence to consent to treatment can be assessed by her ability to:<ul><li>Understand the information provided, and</li><li>Weigh up the risks and benefits, and</li><li>Express her own wishes.</li></ul></li><li>Young people should be assured that the consultation is confidential and informed of the circumstances in which confidentiality may need to be breached (for example, suspected child protection issues, exploitation, or coercion).</li><li>Women with learning and/or physical disabilities should be supported in making their own decisions about contraception. </li></ul><!-- end field df77852f-535d-4b1f-84dd-32803bfb49bb --><!-- end item 1c61fd36-ff66-4f8c-a7db-7f8b57504d39 -->","topic":{"id":"b3143012-a228-55f5-8507-b5b650690e4c","topicId":"32f1df2c-afc0-4f35-be88-49caf8770b41","topicName":"Contraception - assessment","slug":"contraception-assessment","aliases":[],"chapters":[{"id":"8d7c8a25-4e93-5a42-928f-f6611bb74f8b","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"f6467a38-cb74-5956-9113-c5ea6b3e26b3","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"6121a83b-02e9-52ac-a8f9-0998004484bc","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"07b5f362-627f-5d8a-8d01-b917142582c2","slug":"changes","fullItemName":"Changes"},{"id":"0df9a885-e331-5bb2-aa56-e9c271c953dc","slug":"update","fullItemName":"Update"}]},{"id":"699be09a-1785-5ab5-bf3b-cf106ce69b83","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"d59c7a2c-4736-5055-b01b-29e6039bc23b","slug":"goals","fullItemName":"Goals"},{"id":"8e96e0e4-38c0-5981-bfd3-d340e227337e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"df0725fd-cf61-5019-a02b-7c6e05ca6d55","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"86b18852-547f-5859-960f-b4512c2736c1","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"61cea463-ab64-5105-8179-666b624b775b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8d52411f-5b91-53ff-87d9-703de7ff4ff1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d6a02d9d-3223-585d-89bb-915cc73d1565","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"c6218ca2-8f9c-534f-95be-c1a373a78494","slug":"comparative-effectiveness-of-contraceptive-methods","fullItemName":"Comparative effectiveness of contraceptive methods"},{"id":"1e7241c0-cd2e-5c44-a7d0-01f505a5f6df","slug":"available-contraceptive-methods-in-the-uk","fullItemName":"Available contraceptive methods in the UK"}]},{"id":"f66ce071-5b93-583d-8904-2d6f862b75ea","slug":"management","fullItemName":"Management","subChapters":[{"id":"de31dc4a-7073-5d0b-83fb-9e0af6e49a7b","slug":"issues-to-consider-discuss","fullItemName":"Scenario: Issues to consider and discuss"},{"id":"10acf1be-13df-5c89-8f9c-6c905784040b","slug":"comorbidities-special-situations","fullItemName":"Scenario: Comorbidities and special situations"},{"id":"04a5ef68-fad9-5897-8a64-10294e5004a2","slug":"prescribing-to-young-people","fullItemName":"Scenario: Prescribing to young people"},{"id":"012d4729-63d2-51ca-a18c-bbd593b74fa4","slug":"approaching-the-menopause","fullItemName":"Scenario: Approaching the menopause"},{"id":"5970d6e3-da30-5c77-b143-090babc6df1b","slug":"assessment-for-specific-contraceptive-methods","fullItemName":"Scenario: Assessment for specific contraceptive methods"}]},{"id":"1f285502-649a-5805-a56d-1819aafe2ef0","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"2c624d48-ad5c-53e5-afd7-03cbcb0af45d","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"040eb257-bbbd-5695-8eda-cde5a6b0991e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"582f4ca4-299f-54d7-ac03-285acee6a6d6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c6171063-570c-5710-a837-052779620da6","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"278eb9ce-8d46-577d-bc1b-19866cb57433","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7e6a7d96-a9eb-5bb8-bb74-9a82eb3efeaa","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"83baf2bb-d418-5417-9e87-94f055e1ea8a","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"b3143012-a228-55f5-8507-b5b650690e4c","topicId":"32f1df2c-afc0-4f35-be88-49caf8770b41","topicName":"Contraception - assessment","slug":"contraception-assessment","aliases":[],"topicSummary":"An assessment should be carried out on all women requesting contraception to identify any relevant medical conditions or medication","lastRevised":"Last revised in September 2019","nextPlannedReviewBy":"2021-05-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2021-04","nextPlannedReviewByDisplay":"April 2021","specialities":[{"id":"460cf76a-c057-55d8-a7ab-50fe9463f7da","name":"Mental health","slug":"mental-health"},{"id":"36359dab-3569-558a-9136-fb7dcb5a1827","name":"Pregnancy","slug":"pregnancy"},{"id":"f05d0400-7348-5229-ab3e-400d91618189","name":"Sexual health","slug":"sexual-health"},{"id":"0c813417-9691-5826-9371-c4bec6c53f06","name":"Women's health","slug":"womens-health"}],"chapters":[{"id":"8d7c8a25-4e93-5a42-928f-f6611bb74f8b","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"f6467a38-cb74-5956-9113-c5ea6b3e26b3","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"6121a83b-02e9-52ac-a8f9-0998004484bc","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"07b5f362-627f-5d8a-8d01-b917142582c2","slug":"changes","fullItemName":"Changes"},{"id":"0df9a885-e331-5bb2-aa56-e9c271c953dc","slug":"update","fullItemName":"Update"}]},{"id":"699be09a-1785-5ab5-bf3b-cf106ce69b83","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"d59c7a2c-4736-5055-b01b-29e6039bc23b","slug":"goals","fullItemName":"Goals"},{"id":"8e96e0e4-38c0-5981-bfd3-d340e227337e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"df0725fd-cf61-5019-a02b-7c6e05ca6d55","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"86b18852-547f-5859-960f-b4512c2736c1","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"61cea463-ab64-5105-8179-666b624b775b","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8d52411f-5b91-53ff-87d9-703de7ff4ff1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d6a02d9d-3223-585d-89bb-915cc73d1565","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"c6218ca2-8f9c-534f-95be-c1a373a78494","slug":"comparative-effectiveness-of-contraceptive-methods","fullItemName":"Comparative effectiveness of contraceptive methods"},{"id":"1e7241c0-cd2e-5c44-a7d0-01f505a5f6df","slug":"available-contraceptive-methods-in-the-uk","fullItemName":"Available contraceptive methods in the UK"}]},{"id":"f66ce071-5b93-583d-8904-2d6f862b75ea","slug":"management","fullItemName":"Management","subChapters":[{"id":"de31dc4a-7073-5d0b-83fb-9e0af6e49a7b","slug":"issues-to-consider-discuss","fullItemName":"Scenario: Issues to consider and discuss"},{"id":"10acf1be-13df-5c89-8f9c-6c905784040b","slug":"comorbidities-special-situations","fullItemName":"Scenario: Comorbidities and special situations"},{"id":"04a5ef68-fad9-5897-8a64-10294e5004a2","slug":"prescribing-to-young-people","fullItemName":"Scenario: Prescribing to young people"},{"id":"012d4729-63d2-51ca-a18c-bbd593b74fa4","slug":"approaching-the-menopause","fullItemName":"Scenario: Approaching the menopause"},{"id":"5970d6e3-da30-5c77-b143-090babc6df1b","slug":"assessment-for-specific-contraceptive-methods","fullItemName":"Scenario: Assessment for specific contraceptive methods"}]},{"id":"1f285502-649a-5805-a56d-1819aafe2ef0","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"2c624d48-ad5c-53e5-afd7-03cbcb0af45d","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"040eb257-bbbd-5695-8eda-cde5a6b0991e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"582f4ca4-299f-54d7-ac03-285acee6a6d6","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c6171063-570c-5710-a837-052779620da6","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"278eb9ce-8d46-577d-bc1b-19866cb57433","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7e6a7d96-a9eb-5bb8-bb74-9a82eb3efeaa","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"83baf2bb-d418-5417-9e87-94f055e1ea8a","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"b3143012-a228-55f5-8507-b5b650690e4c"}},"staticQueryHashes":["3666801979"]}